Scan to Download ios&Android APP

Trade Brooklyn ImmunoTherapeutics, Inc. - BTX CFD

0.52
6.12%
0.05
Low: 0.48
High: 0.54
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

Brooklyn ImmunoTherapeutics, Inc. live chart

Still looking for a broker you can trust?
Capital.com Group
400,000+

Traders

90,000+

Active clients monthly

$65,000,000+

Monthly investing volume

$29,000,000+

Withdrawn each month

  • Summary
  • Historical Data
Trading Conditions
Long position overnight fee
-0.0225%
Short position overnight fee
-0.0219%
Overnight fee time
21:00 (UTC)
Min traded quantity
1
Currency
USD
Margin
20%
Stock exchange
United States of America
Commission on trade
0%
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 1, 2022 0.52 0.03 6.12% 0.49 0.54 0.48
Jun 30, 2022 0.49 -0.02 -3.92% 0.51 0.51 0.48
Jun 29, 2022 0.51 -0.03 -5.56% 0.54 0.54 0.50
Jun 28, 2022 0.53 -0.04 -7.02% 0.57 0.58 0.52
Jun 27, 2022 0.56 -0.03 -5.08% 0.59 0.59 0.55
Jun 24, 2022 0.57 0.00 0.00% 0.57 0.62 0.55
Jun 23, 2022 0.57 0.04 7.55% 0.53 0.57 0.52
Jun 22, 2022 0.50 0.04 8.70% 0.46 0.50 0.45
Jun 21, 2022 0.45 -0.03 -6.25% 0.48 0.50 0.44
Jun 17, 2022 0.47 -0.02 -4.08% 0.49 0.52 0.47
Jun 16, 2022 0.48 -0.02 -4.00% 0.50 0.50 0.48
Jun 15, 2022 0.52 0.00 0.00% 0.52 0.53 0.51
Jun 14, 2022 0.52 0.01 1.96% 0.51 0.53 0.50
Jun 13, 2022 0.52 -0.05 -8.77% 0.57 0.57 0.52
Jun 10, 2022 0.60 -0.03 -4.76% 0.63 0.64 0.59
Jun 9, 2022 0.67 0.01 1.52% 0.66 0.68 0.63
Jun 8, 2022 0.67 0.08 13.56% 0.59 0.67 0.59
Jun 7, 2022 0.60 0.03 5.26% 0.57 0.62 0.57
Jun 6, 2022 0.59 -0.01 -1.67% 0.60 0.61 0.58
Jun 3, 2022 0.59 -0.01 -1.67% 0.60 0.60 0.58

Content 2
Content 2

Key Stats

Prev. Close* 0.49
Open* 0.49
Day's Range* 0.48 - 0.48
1-Year Change* -3.92%
Volume N/A
Average Vol. (3m) 10.5238
52 wk Range N/A
Market Cap 35.2812
P/E Ratio N/A
Shares Outstanding 57.45M
Revenue N/A
EPS -2.73963
Dividend (Yield %) N/A
Beta 4.92533
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Brooklyn ImmunoTherapeutics, Inc. Company profile

About Brooklyn Immunotherapeutics Inc

Brooklyn ImmunoTherapeutics, Inc. (Brooklyn), formerly NTN Buzztime, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on cytokine-based therapies in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Brooklyn is engaged in developing IRX-2, a cytokine-based therapy, to treat patients with head and neck cancer. IRX-2 is an allogeneic, reproducible, primary, human cell-derived Interleukin-2 (IL-2) therapeutic with multiple active cytokine components that act on various parts of the immune system, to activate the entire tumor microenvironment. In addition to IL-2, IRX-2 contains multiple human cytokines that promote or enhance an immune response. IRX-2 is administered as an injection around lymph node beds.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Brooklyn Immunotherapeutics Inc revenues decreased from $4.6M to $0K. Net loss applicable to common stockholders increased from $4.7M to $113.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other (expense) income, net decrease from $826K (income) to $25K (expense).

Equity composition

Common Stock $.005 Par, 12/10, 84M auth., 61,378,090 issd., less 503,000 shs. in Treas. @ $456K. Insiders & Strategic holders own 24.10%. IPO: 10/84,4M Units (1 Com + 2 Warr.) @ $.05 by Alpine Secs. PO:4/00, 2M shs. @ $3 by Starr Secs. 10% Cum. Preferred Stock $.005 Par, 5M auth.,

Industry: Biotechnology & Medical Research (NEC)

140 58Th Street, Building A
Suite 2100
BROOKLYN
NEW YORK 11220
US

People Also Watch

US Crude Oil Spot

106.67 Price
+1.970% 1D Chg, %
Long position overnight fee 0.0600%
Short position overnight fee -0.0887%
Overnight fee time 21:00 (UTC)
Spread 0.02

Market analysis

Brooklyn ImmunoTherapeutics, Inc. (BTX) Stock Jumps 4.08%: Will It Continue to Soar?

Brooklyn ImmunoTherapeutics, Inc. (BTX) stock is up 4.08% in the last day. For details on what happened in the market, see our analysis.

07:00, 2 July 2022

Learn more about

Still looking for a broker you can trust?

Join the 400.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading